RANKL in turn can bind to RANK on neighboring ER/PR-negative tumor cells and stimulate proliferation of these cells in a paracrine fashion (as demonstrated in Figure 1, pathway IV), reviewed in [83,84]. Here, TNFSF11 is linked to neoplasm.